Defining T-Cell Responses to Mutant and Non-Mutant Antigens in Mouse Melanoma During Anti-CTLA-4 Immune Checkpoint Therapy

Authors

• Amangelin Diore Jalbuena MS, The University of Texas MD Anderson Cancer CenterFollow
• Sunita Keshari PhD, The University of Texas MD Anderson Cancer Center
• Matthew Gubin PhD, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

Neoantigens; Immune Checkpoint Therapy; MLAMA4; MALG8; Therapeutic Cancer Vaccine

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRTP Summer Research Experience

Recommended Citation

Jalbuena, Amangelin Diore MS; Keshari, Sunita PhD; and Gubin, Matthew PhD, "Defining T-Cell Responses to Mutant and Non-Mutant Antigens in Mouse Melanoma During Anti-CTLA-4 Immune Checkpoint Therapy" (2021). Summer Experience 2021. 210.
https://openworks.mdanderson.org/sumexp21/210